PRDX1 and cancer: Compared with the expression levels in normal samples, ABCC5, FDPS, ITGB1BP1, MSH2, PABPC1, PRDX1, SLC25A19 and YWHAH showed significantly high expression levels in most cancer types, while BCL10 was expressed lowly in most cancer types except for CHOL, LIHC, ESCA and STAD.